Platinum Sponsors
AstraZeneca
AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to deliver life-changing medicines to patients. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.
- www.astrazeneca.com
- Booth no. 1.4
Daiichi Sankyo
With more than 120 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 17,000 employees around the world draw upon a rich legacy of innovation to realize our 2030 Vision to become an Innovative Global Healthcare Company Contributing to the Sustainable Development of Society.
- www.daiichisankyo.com
- Booth no. 1.1
Pfizer Oncology
Pfizer Oncology is at the forefront of a new era in cancer care. Our industry-leading portfolio and pipeline includes game-changing mechanisms of action to attack cancer from multiple angles, including antibody-drug conjugates (ADCs), small molecules, bispecifics and other immunotherapies. Driven by science, we are committed to accelerating breakthroughs to extend and improve the lives of people living with some of the world’s most common cancers.
- www.pfizer.com
- Booth no. 1.2
Roche
Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world.
- www.roche.com
- Booth no. 1.6
Gold Sponsors
Eli Lilly and Company
Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe.
- www.lilly.com
- Booth no. 1.3
Exact Sciences
Exact Sciences is a leading, global cancer diagnostics company. From early detection to diagnosis and treatment guidance, the company is offering and further developing a suite of tests to enable personalized care at all stages of the disease. In early breast cancer, the Oncotype DX test is the only test validated to identify patients likely to benefit from chemotherapy.
- www.exactsciences.com
- Booth no. 2.16
Laboratoires Pierre Fabre
Pierre Fabre Laboratories, one of Europe's leading pharmaceutical companies has 43 years in oncology innovation. In 2023, 50% of R&D budget was allocated to targeted therapies. Its portfolio of oncology specialties covers colorectal, breast, melanoma, lung cancers and more. Founded in 1962, the company proudly manufactures 95% of its products in France, employing around 10.000 people worldwide.
- www.pierre-fabre.com
- Booth no. 2.12
Menarini Stemline
Menarini Stemline is committed to making a difference in cancer patients’ lives. We invest in developing precision medicine through our pipeline of investigational drugs. Partnering with cancer experts and research institutions globally, we aim to improve our outstanding cancer to enable personalized care from early detection to precision medicine.
- www.menarinistemline.com
- Booth no. 2.11
MSD
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the US and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases.
- www.msd.com
- Booth no. 1.9
Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
- www.novartis.com
- Booth no. 1.10
Exhibitors
Agendia NV
Agendia is a leader in precision oncology diagnostics for early-stage breast cancer. Agendia’s MammaPrint and BluePrint genomic assays illuminate tumor biology to help optimize patients’ treatment plans, at time of diagnosis, minimizing risks of over- and undertreatment. With cutting-edge technology and a commitment to innovation, Agendia strives to shape the future of precision oncology and combat breast cancer effectively.
Asuragen, a Bio-Techne brand
Asuragen delivers innovative molecular diagnostic solutions in genetics, oncology, and reproductive health. Our proprietary technology, optimised for widely available instruments, simplifies adoption and expands lab test menus. With over 20 years of expertise, we address evolving clinical needs through advanced diagnostic systems and target-specific molecular controls for reliable, high-performing results.
- www.asuragen.com
- Booth no. 2.10
Menarini Silicon Biosystems
Menarini Silicon Biosystems is a pioneer in the field of circulating tumor cell (CTC) analysis, and its proprietary CELLSEARCH® CTC Test is the first and only clinically validated, FDA-cleared test for detecting and counting CTCs to aid physicians in managing metastatic breast cancer patients when used in conjunction with other clinical methods of monitoring. Menarini Silicon Biosystems is part of the Menarini Group.
- www.siliconbiosystems.com
- Booth no. 2.17
Stratipath
Stratipath is an AI company dedicated to revolutionising cancer treatment decisions and enhancing patient outcomes. The pioneering solution Stratipath Breast is the first AI-based prognostic risk profiling tool, regulatory aligned for clinical use. The solution provides prognostic information on the risk of disease progression. It is already in clinical use and validated in large-scale studies.
- www.stratipath.com
- Booth no. 2.15
Societies
ABC Global Alliance
The ABC Global Alliance established in 2016 as an initiative of the European School of Oncology and now registered as a non-profit association in Portugal, is a multi-stakeholder platform for all those interested in collaborating on common projects relating to advanced breast cancer with the aim to improve and extend the lives of women and men living with ABC in all countries worldwide and to fight for a cure.